Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Appointed director
Quarterly results
Director departure
ACHILLION PHARMACEUTICALS INC (ACHN) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/23/2020 SC 13G GOLDMAN SACHS GROUP INC reports a 5.2% stake in ACHILLION PHARMACEUTICALS, INC.
01/16/2020 SC 13G ARP AMERICAS LLC reports a 5.4% stake in Achillion Pharmaceuticals, Inc.
02/08/2019 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
09/28/2017 SC 13G RTW INVESTMENTS, LLC reports a 5.2% stake in Achillion Pharmaceuticals, Inc.
02/16/2016 SC 13G ACHILLION PHARMACEUTICALS INC reports a 5.1% stake in ACHILLION PHARMACEUTICALS, INC.
10/04/2013 SC 13G RA CAPITAL MANAGEMENT, LLC reports a 15% stake in Achillion Pharmaceuticals, Inc.
09/07/2012 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
04/08/2011 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
08/30/2010 SC 13G Quaker BioVentures II LP reports a 10.9% stake in Achillion Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy